228 related articles for article (PubMed ID: 29109161)
1. Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.
Andersson JA; Sha J; Kirtley ML; Reyes E; Fitts EC; Dann SM; Chopra AK
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109161
[TBL] [Abstract][Full Text] [Related]
2. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.
Andersson JA; Fitts EC; Kirtley ML; Ponnusamy D; Peniche AG; Dann SM; Motin VL; Chauhan S; Rosenzweig JA; Sha J; Chopra AK
Antimicrob Agents Chemother; 2016 Jun; 60(6):3717-29. PubMed ID: 27067323
[TBL] [Abstract][Full Text] [Related]
3. New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
Andersson JA; Peniche AG; Galindo CL; Boonma P; Sha J; Luna RA; Savidge TC; Chopra AK; Dann SM
mBio; 2020 Mar; 11(2):. PubMed ID: 32156806
[TBL] [Abstract][Full Text] [Related]
4. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
[TBL] [Abstract][Full Text] [Related]
5. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.
Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK
Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160
[TBL] [Abstract][Full Text] [Related]
6. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy.
Wang J; Sha J; Strong E; Chopra AK; Lee S
Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262
[TBL] [Abstract][Full Text] [Related]
7. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice.
Bubeck SS; Cantwell AM; Dube PH
Infect Immun; 2007 Feb; 75(2):697-705. PubMed ID: 17101642
[TBL] [Abstract][Full Text] [Related]
8. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
[TBL] [Abstract][Full Text] [Related]
9. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
10. Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
Carlson-Banning KM; Chou A; Liu Z; Hamill RJ; Song Y; Zechiedrich L
PLoS One; 2013; 8(7):e69646. PubMed ID: 23936064
[TBL] [Abstract][Full Text] [Related]
11. Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.
Zauberman A; Tidhar A; Levy Y; Bar-Haim E; Halperin G; Flashner Y; Cohen S; Shafferman A; Mamroud E
PLoS One; 2009 Jun; 4(6):e5938. PubMed ID: 19529770
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK
Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.
van Lier CJ; Sha J; Kirtley ML; Cao A; Tiner BL; Erova TE; Cong Y; Kozlova EV; Popov VL; Baze WB; Chopra AK
Infect Immun; 2014 Jun; 82(6):2485-503. PubMed ID: 24686064
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.
Lin YW; Zhou QT; Han ML; Chen K; Onufrak NJ; Wang J; Turnidge JD; Howden BP; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637
[TBL] [Abstract][Full Text] [Related]
16. Treatment with Fluticasone Propionate Increases Antibiotic Efficacy during Treatment of Late-Stage Primary Pneumonic Plague.
Crane SD; Banerjee SK; Pechous RD
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0127521. PubMed ID: 34780267
[TBL] [Abstract][Full Text] [Related]
17. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
[TBL] [Abstract][Full Text] [Related]
18. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.
Sha J; Rosenzweig JA; Kirtley ML; van Lier CJ; Fitts EC; Kozlova EV; Erova TE; Tiner BL; Chopra AK
Microb Pathog; 2013 Feb; 55():39-50. PubMed ID: 23063826
[TBL] [Abstract][Full Text] [Related]
19. Identification of New Virulence Factors and Vaccine Candidates for
Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
[TBL] [Abstract][Full Text] [Related]
20. Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae.
Vázquez-Ucha JC; Martínez-Guitián M; Lasarte-Monterrubio C; Conde-Pérez K; Arca-Suárez J; Álvarez-Fraga L; Pérez A; Crecente-Campo J; Alonso MJ; Bou G; Poza M; Beceiro A
Biomed Pharmacother; 2020 Oct; 130():110606. PubMed ID: 32795924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
